The global Tuberculosis Vaccine Treatment market was valued at 6.97 Million USD in 2020 and will grow with a CAGR of 2.99% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme. Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive. In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%. The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%. Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%. Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%. Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.
By Market Verdors:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
By Types:
Immune Vaccine
Therapy Vaccine
By Applications:
Self-Procurement
UNICEF
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Tuberculosis Vaccine Treatment Market Size Analysis from 2022 to 2027
1.5.1 Global Tuberculosis Vaccine Treatment Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Tuberculosis Vaccine Treatment Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Tuberculosis Vaccine Treatment Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Tuberculosis Vaccine Treatment Industry Impact
Chapter 2 Global Tuberculosis Vaccine Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Tuberculosis Vaccine Treatment (Volume and Value) by Type
2.1.1 Global Tuberculosis Vaccine Treatment Consumption and Market Share by Type (2016-2021)
2.1.2 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Type (2016-2021)
2.2 Global Tuberculosis Vaccine Treatment (Volume and Value) by Application
2.2.1 Global Tuberculosis Vaccine Treatment Consumption and Market Share by Application (2016-2021)
2.2.2 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Application (2016-2021)
2.3 Global Tuberculosis Vaccine Treatment (Volume and Value) by Regions
2.3.1 Global Tuberculosis Vaccine Treatment Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Tuberculosis Vaccine Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Tuberculosis Vaccine Treatment Consumption by Regions (2016-2021)
4.2 North America Tuberculosis Vaccine Treatment Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Tuberculosis Vaccine Treatment Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Tuberculosis Vaccine Treatment Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Tuberculosis Vaccine Treatment Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Tuberculosis Vaccine Treatment Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Tuberculosis Vaccine Treatment Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Tuberculosis Vaccine Treatment Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Tuberculosis Vaccine Treatment Sales, Consumption, Export, Import (2016-2021)
4.10 South America Tuberculosis Vaccine Treatment Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Tuberculosis Vaccine Treatment Market Analysis
5.1 North America Tuberculosis Vaccine Treatment Consumption and Value Analysis
5.1.1 North America Tuberculosis Vaccine Treatment Market Under COVID-19
5.2 North America Tuberculosis Vaccine Treatment Consumption Volume by Types
5.3 North America Tuberculosis Vaccine Treatment Consumption Structure by Application
5.4 North America Tuberculosis Vaccine Treatment Consumption by Top Countries
5.4.1 United States Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
5.4.2 Canada Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
5.4.3 Mexico Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
Chapter 6 East Asia Tuberculosis Vaccine Treatment Market Analysis
6.1 East Asia Tuberculosis Vaccine Treatment Consumption and Value Analysis
6.1.1 East Asia Tuberculosis Vaccine Treatment Market Under COVID-19
6.2 East Asia Tuberculosis Vaccine Treatment Consumption Volume by Types
6.3 East Asia Tuberculosis Vaccine Treatment Consumption Structure by Application
6.4 East Asia Tuberculosis Vaccine Treatment Consumption by Top Countries
6.4.1 China Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
6.4.2 Japan Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
6.4.3 South Korea Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
Chapter 7 Europe Tuberculosis Vaccine Treatment Market Analysis
7.1 Europe Tuberculosis Vaccine Treatment Consumption and Value Analysis
7.1.1 Europe Tuberculosis Vaccine Treatment Market Under COVID-19
7.2 Europe Tuberculosis Vaccine Treatment Consumption Volume by Types
7.3 Europe Tuberculosis Vaccine Treatment Consumption Structure by Application
7.4 Europe Tuberculosis Vaccine Treatment Consumption by Top Countries
7.4.1 Germany Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
7.4.2 UK Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
7.4.3 France Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
7.4.4 Italy Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
7.4.5 Russia Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
7.4.6 Spain Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
7.4.7 Netherlands Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
7.4.8 Switzerland Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
7.4.9 Poland Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
Chapter 8 South Asia Tuberculosis Vaccine Treatment Market Analysis
8.1 South Asia Tuberculosis Vaccine Treatment Consumption and Value Analysis
8.1.1 South Asia Tuberculosis Vaccine Treatment Market Under COVID-19
8.2 South Asia Tuberculosis Vaccine Treatment Consumption Volume by Types
8.3 South Asia Tuberculosis Vaccine Treatment Consumption Structure by Application
8.4 South Asia Tuberculosis Vaccine Treatment Consumption by Top Countries
8.4.1 India Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
8.4.2 Pakistan Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Tuberculosis Vaccine Treatment Market Analysis
9.1 Southeast Asia Tuberculosis Vaccine Treatment Consumption and Value Analysis
9.1.1 Southeast Asia Tuberculosis Vaccine Treatment Market Under COVID-19
9.2 Southeast Asia Tuberculosis Vaccine Treatment Consumption Volume by Types
9.3 Southeast Asia Tuberculosis Vaccine Treatment Consumption Structure by Application
9.4 Southeast Asia Tuberculosis Vaccine Treatment Consumption by Top Countries
9.4.1 Indonesia Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
9.4.2 Thailand Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
9.4.3 Singapore Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
9.4.4 Malaysia Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
9.4.5 Philippines Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
9.4.6 Vietnam Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
9.4.7 Myanmar Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
Chapter 10 Middle East Tuberculosis Vaccine Treatment Market Analysis
10.1 Middle East Tuberculosis Vaccine Treatment Consumption and Value Analysis
10.1.1 Middle East Tuberculosis Vaccine Treatment Market Under COVID-19
10.2 Middle East Tuberculosis Vaccine Treatment Consumption Volume by Types
10.3 Middle East Tuberculosis Vaccine Treatment Consumption Structure by Application
10.4 Middle East Tuberculosis Vaccine Treatment Consumption by Top Countries
10.4.1 Turkey Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
10.4.3 Iran Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
10.4.5 Israel Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
10.4.6 Iraq Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
10.4.7 Qatar Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
10.4.8 Kuwait Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
10.4.9 Oman Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
Chapter 11 Africa Tuberculosis Vaccine Treatment Market Analysis
11.1 Africa Tuberculosis Vaccine Treatment Consumption and Value Analysis
11.1.1 Africa Tuberculosis Vaccine Treatment Market Under COVID-19
11.2 Africa Tuberculosis Vaccine Treatment Consumption Volume by Types
11.3 Africa Tuberculosis Vaccine Treatment Consumption Structure by Application
11.4 Africa Tuberculosis Vaccine Treatment Consumption by Top Countries
11.4.1 Nigeria Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
11.4.2 South Africa Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
11.4.3 Egypt Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
11.4.4 Algeria Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
11.4.5 Morocco Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
Chapter 12 Oceania Tuberculosis Vaccine Treatment Market Analysis
12.1 Oceania Tuberculosis Vaccine Treatment Consumption and Value Analysis
12.2 Oceania Tuberculosis Vaccine Treatment Consumption Volume by Types
12.3 Oceania Tuberculosis Vaccine Treatment Consumption Structure by Application
12.4 Oceania Tuberculosis Vaccine Treatment Consumption by Top Countries
12.4.1 Australia Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
12.4.2 New Zealand Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
Chapter 13 South America Tuberculosis Vaccine Treatment Market Analysis
13.1 South America Tuberculosis Vaccine Treatment Consumption and Value Analysis
13.1.1 South America Tuberculosis Vaccine Treatment Market Under COVID-19
13.2 South America Tuberculosis Vaccine Treatment Consumption Volume by Types
13.3 South America Tuberculosis Vaccine Treatment Consumption Structure by Application
13.4 South America Tuberculosis Vaccine Treatment Consumption Volume by Major Countries
13.4.1 Brazil Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
13.4.2 Argentina Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
13.4.3 Columbia Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
13.4.4 Chile Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
13.4.5 Venezuela Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
13.4.6 Peru Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
13.4.8 Ecuador Tuberculosis Vaccine Treatment Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Tuberculosis Vaccine Treatment Business
14.1 Merck
14.1.1 Merck Company Profile
14.1.2 Merck Tuberculosis Vaccine Treatment Product Specification
14.1.3 Merck Tuberculosis Vaccine Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Japan BCG Lab
14.2.1 Japan BCG Lab Company Profile
14.2.2 Japan BCG Lab Tuberculosis Vaccine Treatment Product Specification
14.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Serum Institute of India
14.3.1 Serum Institute of India Company Profile
14.3.2 Serum Institute of India Tuberculosis Vaccine Treatment Product Specification
14.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 AJ Vaccines
14.4.1 AJ Vaccines Company Profile
14.4.2 AJ Vaccines Tuberculosis Vaccine Treatment Product Specification
14.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 BioFarma
14.5.1 BioFarma Company Profile
14.5.2 BioFarma Tuberculosis Vaccine Treatment Product Specification
14.5.3 BioFarma Tuberculosis Vaccine Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 GreenSignal Bio Pharma
14.6.1 GreenSignal Bio Pharma Company Profile
14.6.2 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Specification
14.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 China National Biotec
14.7.1 China National Biotec Company Profile
14.7.2 China National Biotec Tuberculosis Vaccine Treatment Product Specification
14.7.3 China National Biotec Tuberculosis Vaccine Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Biomed Lublin
14.8.1 Biomed Lublin Company Profile
14.8.2 Biomed Lublin Tuberculosis Vaccine Treatment Product Specification
14.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Taj Pharmaceuticals
14.9.1 Taj Pharmaceuticals Company Profile
14.9.2 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Specification
14.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Ataulpho de Paiva
14.10.1 Ataulpho de Paiva Company Profile
14.10.2 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Specification
14.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 IVAC
14.11.1 IVAC Company Profile
14.11.2 IVAC Tuberculosis Vaccine Treatment Product Specification
14.11.3 IVAC Tuberculosis Vaccine Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Queen Saovabha Mem. Inst
14.12.1 Queen Saovabha Mem. Inst Company Profile
14.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Specification
14.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Microgen
14.13.1 Microgen Company Profile
14.13.2 Microgen Tuberculosis Vaccine Treatment Product Specification
14.13.3 Microgen Tuberculosis Vaccine Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Tuberculosis Vaccine Treatment Market Forecast (2022-2027)
15.1 Global Tuberculosis Vaccine Treatment Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Tuberculosis Vaccine Treatment Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Tuberculosis Vaccine Treatment Value and Growth Rate Forecast (2022-2027)
15.2 Global Tuberculosis Vaccine Treatment Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Tuberculosis Vaccine Treatment Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Tuberculosis Vaccine Treatment Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Tuberculosis Vaccine Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Tuberculosis Vaccine Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Tuberculosis Vaccine Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Tuberculosis Vaccine Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Tuberculosis Vaccine Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Tuberculosis Vaccine Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Tuberculosis Vaccine Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Tuberculosis Vaccine Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Tuberculosis Vaccine Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Tuberculosis Vaccine Treatment Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Tuberculosis Vaccine Treatment Consumption Forecast by Type (2022-2027)
15.3.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Type (2022-2027)
15.3.3 Global Tuberculosis Vaccine Treatment Price Forecast by Type (2022-2027)
15.4 Global Tuberculosis Vaccine Treatment Consumption Volume Forecast by Application (2022-2027)
15.5 Tuberculosis Vaccine Treatment Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Mar 2024 |
| Category : Services |
Pages : 120 |
Request Sample 
Request Discount 
Inquire Before Buy
